Christopher Dylan Chambliss, APRN

Christopher Chambliss practices at Wyandot Memorial Hospital in Upper Sandusky, Ohio, part of Wyandot Memorial Hospital.

Christopher Chambliss' NPI, 1801489497, was assigned on February 16, 2021. Christopher Chambliss holds Florida license APRN1101662.

Christopher Chambliss' primary practice is Wyandot Memorial Hospital, at 885 North Sandusky Avenue, Upper Sandusky, OH 43351 in Wyandot County. The practice phone is (419) 294-4991.

Christopher Chambliss' primary practice is Wyandot Memorial Hospital in Upper Sandusky, Ohio, part of Wyandot Memorial Hospital. Christopher Chambliss is also affiliated with UF Health Shands Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Christopher Chambliss to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Chambliss practices, 8 sites in all. Vendor and product names are available with a free account.

Family is Christopher Chambliss' primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Christopher Chambliss is licensed in Florida.

CMS data shows 17 Medicare services from Christopher Chambliss across 1 procedure code in 2024, all of them office visits, for 27 Medicare patients. Medicare paid $1,436 for them. Every service was in an office.

CMS counts 27 Medicare patients who saw Christopher Chambliss in 2024. The largest group is 75 to 84, with 11 patients. 75% of them have diabetes, and 75% have high blood pressure. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Chambliss' median patient age at 68, with 58% women.

In 2024, Christopher Chambliss wrote 3,507 Medicare Part D claims for 910 patients. 39% of them were for generic drugs. CMS names the drug for 2,990 of them, across 57 drugs with 11 or more claims each, at $1,561,369 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Christopher Chambliss for performance year 2024, reported through an alternative payment model (APM). Christopher Chambliss accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Chambliss as offering telehealth.

CMS Open Payments shows 2 general payments to Christopher Chambliss from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $125.